Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CETP | P11597 | 1/20 | 0.47 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.43 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12798033 | 1.00 | GAA (0.50) | GAACETPSYNJ2L3MBTL1TYR | |
| SCHEMBL21245905 | 1.00 | GAA (0.50) | GAACETPSYNJ2L3MBTL1TYR | |
| SCHEMBL7153515 | 1.00 | GAA (0.50) | GAACETPSYNJ2L3MBTL1TYR | |
| SCHEMBL12604144 | 1.00 | GAA (0.50) | GAACETPSYNJ2L3MBTL1TYR | |
| SCHEMBL1782020 | 1.00 | GAA (0.50) | GAACETPSYNJ2L3MBTL1TYR | |
| SCHEMBL21245904 | 1.00 | GAA (0.50) | GAACETPSYNJ2L3MBTL1TYR | |
| Isomalt SCHEMBL21140452 | 0.95 | GAA (0.47) | GAACETPSYNJ2L3MBTL1TYR | |
| Isomalt SCHEMBL21808054 | 0.95 | GAA (0.47) | GAACETPSYNJ2L3MBTL1TYR | |
| Isomalt SCHEMBL371450 | 0.95 | GAA (0.47) | GAACETPSYNJ2L3MBTL1TYR | |
| Isomalt SCHEMBL22516557 | 0.95 | GAA (0.47) | GAACETPSYNJ2L3MBTL1TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987216-B2 | Polysulfated glycosides and salts thereof | Teva Hungary Pharmaceutical Marketing Private Limited Company (HU) | 2015-03-24 | — | — | US | disclosed |
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RESEARCH INSTITUTE LTD. (HU) | 2011-05-19 | — | — | US | disclosed |
| US-7902158-B2 | Polysulfated glycosides and salts thereof | Ivax Drug Research Ltd. (HU) | 2011-03-08 | — | — | US | disclosed |
| EP-1778709-B1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RES INST LTD (HU) | 2008-05-28 | — | — | EP | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | CFTR, AREG, STS | GAA 217/4885CETP 1084/4885SYNJ2 3079/4885 |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | CFTR, AREG, STS | GAA 217/4885CETP 1084/4885SYNJ2 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.